High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.6M
$3,605,098
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
Other
|
2026-03-09 | $759,804x4 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Ragosa Mark
• CFO
10b5-1 SellΔOwn -36.8%
2026-03-09
$1,686,158Largex2
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
CFO
10b5-1 SellΔOwn -36.8%
|
2026-03-09 | $1,686,158Largex2 | S | Form 4 |
|
KNSA
M
Kiniksa Pharmaceuticals International, plc
Paolini John F.
• Officer • CHIEF MEDICAL OFFICER
Other
2026-03-02
$414,400
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Officer • CHIEF MEDICAL OFFICER
Other
|
2026-03-02 | $414,400 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Paolini John F.
• Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
2026-03-02
$1,792,940Largex3
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Officer • CHIEF MEDICAL OFFICER
10b5-1 Sell
|
2026-03-02 | $1,792,940Largex3 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
Other
|
2026-02-12 | $41,614 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
10b5-1 SellΔOwn -17.7%
2026-02-12
$121,050
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
10b5-1 SellΔOwn -17.7%
|
2026-02-12 | $121,050 | S | Form 4 |
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
Other
|
2026-02-10 | $1,702 | M | Form 4 |
|
KNSA
S
Kiniksa Pharmaceuticals International, plc
Quart Barry D
• Director
10b5-1 Sell
2026-02-10
$4,950
|
||||||
| KNSA |
Kiniksa Pharmaceuticals International, plc
|
Director
10b5-1 Sell
|
2026-02-10 | $4,950 | S | Form 4 |